Research Article
Pre-Emptive OCT-Guided Angioplasty of Vulnerable Intermediate Coronary Lesions: Results from the Prematurely Halted PECTUS-Trial
Table 1
Inclusion and exclusion criteria.
| Inclusion criteria | Exclusion criteria |
| Clinical | Clinical | (i) Age ≥18 years | (i) Pregnancy | (ii) Clinical presentation of STEMI or NSTEMI | (ii) Severe kidney disease defined as an eGFR <30 ml/min | | (iii) Previous CABG | | (iv) Indication for revascularization by CABG | | (v) Estimated life expectancy <1 year |
| Angiographical | Angiographical | (i) Presence of residual, intermediate CAD (diameter stenosis of 30–90%), with the possibility of plaque vulnerability | (i) Target vessel diameter <2.5 mm or >4.0 mm | | (ii) Anatomy of lesion unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, and severe calcifications) | | (iii) Anatomy unsuitable for BVS placement (left main, bifurcation, and side branch (>2 mm) involvement) | | (iv) Target lesion is | | (a) In-stent restenosis | | (b) Chronic total occlusion | | (c) In the same vessel as treated culprit lesion | | (d) In the same segment as a previously implanted stent/scaffold |
|
|
BVS, bioresorbable vascular scaffold, CABG, coronary artery bypass grafting, CAD, coronary artery disease, NSTEMI, Non-ST-elevation myocardial infarction, OCT, optical coherence tomography, STEMI, ST-elevation myocardial infarction.
|